Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1891-2019Class II

RNeasy DSP FFPE Kit (48), REF 73604 -

Qiagen / initiated 2019-05-06 / Terminated

Qiagen Sciences, Inc. began a recall of RNeasy DSP FFPE Kit (48), REF 73604 - Product Usage: The RNeasy DSP FFPE Kit is a system intended for the purification of total RNA from formalin-fixed... on . FDA classified it as Class II and gives the reason as "The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-1891-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Qiagen
Product
RNeasy DSP FFPE Kit (48), REF 73604 - Product Usage: The RNeasy DSP FFPE Kit is a system intended for the purification of total RNA from formalin-fixed, paraffin embedded (FFPE) tissues. The product is intended to be used by professional users, such as technicians and physicians that are trained in molecular biological techniques. It deploys an optimized silica spin-column-based protocol, and includes enzymatic removal of residual DNA. The RNeasy DSP FFPE Kit is intended for in vitro diagnostic use.
Product code
NTW System, Blood Collection, Rna Stabilization, Rna Purification, Rt-Pcr Molecular Diagnostic Test
Reason for recall
The deparaffinization solution contains a contaminant, which leads to reduced lysis efficiency of the affected lot, resulting in significantly reduced yields and less sensitive downstream applications.
FDA root cause
Under Investigation by firm
Action
Urgent Notice of Product Field Action dated 5/6/19 were emailed to customers.
Quantity in commerce
31
Distribution
US nationwide distribution in the states of MA, RI, AZ, NY, NC, IN, TX. The products were distributed to the following foreign countries: Germany, Great Britain, Italy, France, Sweden, and Switzerland.
Product codes and lots
LOT 163016105

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1891-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1891-2019Class IITerminatedVoluntary: Firm initiated